Skip to main content

Antikor Biopharma Ltd

Website

Antikor Ltd is a newly-established company that is exploiting its proprietary technology platform called OptiLink to generate revolutionary products to treat difficult solid cancers. We are a multidisciplinary spin-out from Imperial College London UK now based at the Stevenage Bioscience Catalyst. The Company has over 15 years of pioneering experience in the area of small-format, antibody fragment drug conjugates (FDCs). These are unique in having high drug loadings and rapid tumour penetration, making them more efficacious which with their rapid clearance from normal tissues has the potential to reduce side-effects. Antikor has generated product candidates with optimal pharmacokinetics, pharmacodynamics and other encouraging preclinical data.

Get job alerts from Antikor Biopharma Ltd straight to your inbox